Evaluation of NWRD09 for HPV-16 Related Cervical HSIL
NCT07712692
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
156
Enrollment
INDUSTRY
Sponsor class
Conditions
High-grade Squamous Intraepithelial Lesion (HSIL)
Interventions
BIOLOGICAL:
NWRD09 Injection
BIOLOGICAL:
NWRD09 Placebo
Sponsor
Newish Biotech (Wuxi) Co., Ltd.